Mitsubishi Ufj Trust & Banking Corp Neurocrine Biosciences Inc Transaction History

Mitsubishi Ufj Trust & Banking Corp

$43.4 Billion
Q3 2024

A detailed history of Mitsubishi Ufj Trust & Banking Corp transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Mitsubishi Ufj Trust & Banking Corp holds 125,720 shares of NBIX stock, worth $15.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

125,720

Previous 124,909 0.65%

Holding current value

$15.9 Million

Previous $17.2 Million 15.83%

% of portfolio

0.03%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$114.58 - $153.15 $92,924 - $124,204	811 Added 0.65%	125,720 $14.5 Million
Q2 2024 Aug 08, 2024	BUY	$130.86 - $143.19 $1.6 Million - $1.75 Million	12,191 Added 10.82%	124,909 $17.2 Million
Q1 2024 May 10, 2024	SELL	$130.4 - $143.74 $587,973 - $648,123	-4,509 Reduced 3.85%	112,718 $15.5 Million
Q4 2023 Feb 09, 2024	BUY	$106.07 - $132.76 $1.98 Million - $2.48 Million	18,687 Added 18.96%	117,227 $15.4 Million
Q3 2023 Nov 09, 2023	SELL	$94.02 - $117.1 $45,223 - $56,325	-481 Reduced 0.49%	98,540 $11.1 Million
Q2 2023 Aug 08, 2023	BUY	$89.53 - $104.87 $824,392 - $965,642	9,208 Added 10.25%	99,021 $9.34 Million
Q1 2023 May 10, 2023	BUY	$94.11 - $123.02 $878,046 - $1.15 Million	9,330 Added 11.59%	89,813 $9.09 Million
Q4 2022 Feb 10, 2023	BUY	$106.72 - $127.06 $217,602 - $259,075	2,039 Added 2.6%	80,483 $9.61 Million
Q3 2022 Nov 10, 2022	SELL	$92.03 - $107.81 $2.76 Million - $3.23 Million	-29,938 Reduced 27.62%	78,444 $8.33 Million
Q2 2022 Aug 09, 2022	BUY	$75.79 - $100.07 $1.85 Million - $2.44 Million	24,344 Added 28.97%	108,382 $10.6 Million
Q1 2022 May 12, 2022	SELL	$72.45 - $94.81 $893,670 - $1.17 Million	-12,335 Reduced 12.8%	84,038 $7.88 Million
Q4 2021 Feb 09, 2022	BUY	$79.65 - $106.22 $2.74 Million - $3.65 Million	34,348 Added 55.38%	96,373 $8.21 Million
Q3 2021 Nov 12, 2021	SELL	$86.18 - $99.03 $122,461 - $140,721	-1,421 Reduced 2.24%	62,025 $5.95 Million
Q2 2021 Aug 12, 2021	BUY	$89.43 - $102.27 $550,262 - $629,267	6,153 Added 10.74%	63,446 $6.18 Million
Q1 2021 May 12, 2021	SELL	$87.57 - $119.4 $1.11 Million - $1.51 Million	-12,631 Reduced 18.06%	57,293 $5.57 Million
Q4 2020 Feb 12, 2021	SELL	$86.91 - $108.33 $161,826 - $201,710	-1,862 Reduced 2.59%	69,924 $6.7 Million
Q3 2020 Nov 12, 2020	BUY	$96.16 - $135.15 $228,956 - $321,792	2,381 Added 3.43%	71,786 $6.9 Million
Q2 2020 Sep 11, 2020	SELL	$85.09 - $130.36 $852,176 - $1.31 Million	-10,015 Reduced 12.61%	69,405 $8.47 Million
Q2 2020 Aug 13, 2020	BUY	$85.09 - $130.36 $833,286 - $1.28 Million	9,793 Added 14.06%	79,420 $8.47 Million
Q1 2020 May 13, 2020	BUY	$75.11 - $113.76 $397,482 - $602,017	5,292 Added 8.23%	69,627 $6.03 Million
Q4 2019 Feb 14, 2020	BUY	$86.8 - $118.57 $5.58 Million - $7.63 Million	64,335 New	64,335 $6.92 Million

Others Institutions Holding NBIX

# of Institutions

627

Shares Held

94.3M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.

Account

Mitsubishi Ufj Trust & Banking Corp Neurocrine Biosciences Inc Transaction History